BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 55.20
-0.30 (-0.54%)
At close: Jan 20, 2026
BIONET Therapeutics Company Description
BIONET Therapeutics Corp., a biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.
The company develops treatment for adult respiratory distress syndrome, pulmonary fibrosis, chronic kidney disease, acute wound healing, chronic wound healing of diabetic ulcers, and osteoarthritis.
It also provides CRDMO services. The company was founded in 2022 and is based in Taipei, Taiwan.
BIONET Therapeutics Corp.
| Country | Taiwan |
| Founded | 2022 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 73 |
| CEO | Cheng-Hsien Tsai |
Contact Details
Address: No.28, Xinhu 1st Rd. Taipei, 114065 Taiwan | |
| Phone | 886 2 2795 1777 |
| Website | bionettx.com |
Stock Details
| Ticker Symbol | 7808 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Cheng-Hsien Tsai | Chief Executive Officer |
| Pei Yi Liu | Chief Financial Officer |